The 25th SSBP International Research Symposium: Expanding a Global Perspective on Behavioural Phenotypes.
Most rare-ID syndrome guidelines are weak—push for better methods when you sit on future panels.
01Research in Context
What this study did
A team looked at 70 international guidelines for 28 rare genetic disorders that cause intellectual disability.
They checked how well each guideline was built. They looked for clear search plans, expert agreement steps, and plans for real-world use.
The study covered Angelman, Prader-Willi, and other syndromes you may see once or twice in your career.
What they found
Most guidelines scored low on quality. Few used strong search methods or clear consensus steps.
Only a handful told clinicians how to put the advice into daily practice.
In short, the field has lots of papers called "guidelines" but few that meet high standards.
How this fits with other research
This 2023 review updates and replaces older work. It covers the 2017 accelerometer review by Leung et al. (2017), the 2006 Angelman narrative by Schneider et al. (2006), the 2013 preference-assessment review by Kang et al. (2013), and the 2004 PAS-ADD norm study by Matson et al. (2004).
The new review also echoes the 2003 critique by Katz et al. (2003) that ID research often lacks rigor. Both papers urge better methods, but the 2023 paper focuses on guidelines while the 2003 paper looked at drug studies.
Together, these works show a long-standing gap between what clinicians need and what research delivers.
Why it matters
If you serve on a guideline panel, demand clear search plans and consensus steps. Ask for implementation tools like checklists or parent handouts. Your push for quality will raise the bar for rare-ID care worldwide.
Want CEUs on This Topic?
The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.
Join Free →Before using any new syndrome guideline, check if it lists a clear search plan and gives you ready-to-use parent handouts.
02At a glance
03Original abstract
Background: Individuals with rare genetic neurodevelopmental disorders are often affected with intellectual disability, psychiatric manifestations and complex multi-organ comorbidity, necessitating lifelong and multidisciplinary care. Guidelines can offer valuable support in providing evidence-based care for this population, but their development is challenging. Within the European Reference Network on Rare Congenital Malformations and Rare Intellectual Disability ERN-ITHACA, we create guidelines for genetic syndromes and their shared co-morbidities, while improving our methodology through evidence reviews and qualitative research involving all stakeholders. Assessment of the nature and quality of existing guidelines is needed to inform future guideline development efforts. Methods: We systematically searched MEDLINE, EMBASE and Orphanet for conditions classified as ‘rare genetic intellectual disability’ (ORPHA:183757) to identify guidelines for rare genetic neurodevelopmental disorders. Methodological quality was assessed using the AGREE (Appraisal of Guidelines, Research, and Evaluation) II tool. Results: Seventy internationally published guidelines, addressing the diagnosis and/or management of 28 conditions, were identified and reviewed. Guidelines generally scored well on the definition of topic and scope and clarity of recommendations. Most guidelines were developed by multidisciplinary groups. The extent of involvement of paramedical professionals and affected individuals and families varied. The methodological rigour of development was highly variable with limited reporting of literature searches and consensus methods. Reporting of funding sources was inconsistent, and often there was no procedure for managing conflicts of interest. Implementation aspects were given limited attention. Conclusion: Comprehensive, high-quality guidelines are lacking for many rare neurodevelopmental disorders. Applying rigorous methodology and ensuring applicability are significant challenges in guideline development. This research aims to inform and improve future guideline development processes, contributing to evidence-based care for individuals with rare neurodevelopmental disorders
Journal of intellectual disability research : JIDR, 2023 · doi:10.1111/jir.13074